Chronic respiratory infections by mucoid carbapenemase-producing Pseudomonas aeruginosa strains, a new potential public health problem

Antimicrob Agents Chemother. 2008 Jun;52(6):2285-6. doi: 10.1128/AAC.00076-08. Epub 2008 Apr 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / biosynthesis*
  • Bacterial Proteins / genetics
  • Bronchiectasis / complications
  • Chronic Disease
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Gene Transfer, Horizontal
  • Humans
  • Integrons / genetics
  • Male
  • Pseudomonas Infections / microbiology*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / enzymology
  • Pseudomonas aeruginosa / pathogenicity*
  • Pseudomonas aeruginosa / physiology*
  • Public Health
  • Pulmonary Disease, Chronic Obstructive / complications
  • Respiratory Tract Infections / microbiology*
  • beta-Lactamases / biosynthesis*
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • beta-Lactamases
  • carbapenemase